The expression analysis and its clinical significance of CST1 in bladder translational cell carcinoma

WANG Ya-dong,SUN Liang,LAI Yong-qing,LI Xian-xin,LI Cai-ling,GUAN Zhi-chen,YE Jiong-xian

DOI: https://doi.org/10.3877/cma.j.issn.1674-0785.2012.14.030

2012-01-01

Abstract:Objective To identify the level of CST1 in bladder translational cell carcinoma(BTCC)and analyze its clinical significance on the prognosis of BTCC patients.Methods We examined the expression of CST1 mRNA by real time RT-PCR in 28 paired BTCC and the adjacent normal tissues respectively.The expression of CST1 protein in 85 specimens of BTCC and 16 paired adjacent normal tissues and carcinoma tissue were determined by immunohistochemistry.Statistical analyses were applied to test the relationship between the expression of CST1 and clinical features and recurrence.Results The mRNA level of CST1 was significantly higher in BTCC tissues compared with the adjacent normal tissues by real time RT-PCR(P<0.001).We analysis 85 BTCC specimens by immunohistochemistry and 16 paired tissues.Accordingly,the CST1 protein expression was higher in BTCC tissues compared with the adjacent normal tissues(P<0.001).Moreover,there was a significant correlation between CST1 expression in BTCC and tumor size(P<0.001),Pathologic stage(P=0.016),T stage(P<0.001)and recurrence(P<0.001).Multivariate analysis indicated that CST1 protein upregulation was an independent predictor for high probability of recurrence of bladder cell carcinoma patients.Conclusions Our results indicate that CST1 may represent a novel recurrence marker of bladder cell carcinoma.Patients with higher BTCC expression had greater probability of recurrence than those with lower CST1 expression.Measurement of CST1 expression in primary BTCC can help to stratify the patients for follow-up.